Comprehensive Drug Collection Summary
========================================

Pipeline Drugs Found: 120
FDA Documents: 0
Drugs.com Documents: 21
Clinical Trials: 302
Total Documents: 323
Success: True

Pipeline Drugs by Company:
==============================

Merck & Co.:
------------
    1. Trastuzumab

Bristol Myers Squibb:
---------------------
    1. Elotuzumab
    2. Ipilimumab
    3. Nivolumab

Roche/Genentech:
----------------
    1. Atezolizumab
    2. Trastuzumab

AstraZeneca:
------------
    1. Anselamimab
    2. Bevacizumab
    3. Datopotamab
    4. Datopotamab Deruxtecan
    5. Datroway (Datopotamab Deruxtecan) Tropion-Breast01
    6. Domvanalimab
    7. Gefurulimab
    8. Lenvatinib
    9. Monalizumab
   10. Obinutuzumab
   11. Oleclumab
   12. Osimertinib
   13. Pembrolizumab
   14. Sonesitatug Vedotin
   15. Sonesitatug Vedotin (Azd0901)
   16. Sonesitatug Vedotin (Azd0901)
 - Phase Ii
   17. Sonesitatug Vedotin (Azd0901)
 - Phase Ii


Close
   18. Sonesitatug Vedotin (Azd0901) Clarity-Gastric01
   19. Tozorakimab
   20. Volrustomig + Lenvatinib

Pfizer:
-------
    1. Avelumab

Novartis:
---------
    1. Tisagenlecleucel

Gilead Sciences:
----------------
    1. Yescarta

Amgen:
------
    1. Blinatumomab

Regeneron Pharmaceuticals:
--------------------------
    1. Aflibercept
    2. Cemiplimab
    3. Dupilumab
    4. Fianlimab
    5. Garetosmab
    6. Itepekimab
    7. Linvoseltamab
    8. Mibavademab
    9. Odronextamab
   10. Pozelimab
   11. Sarilumab
   12. Trevogrumab
   13. Ubamatamab

BeiGene:
--------
    1. Acalabrutinib
    2. Blinatumomab
    3. Daratumumab
    4. Durvalamab
    5. Ibrutinib
    6. Osimertinib
    7. Tarlatamab
    8. Tislelizumab
    9. Zanidatamab
   10. Zanubrutinib

Incyte:
-------
    1. Ruxolitinib

Johnson & Johnson:
------------------
    1. Amivantamab
    2. Autoleucel
    3. Bleximenib
    4. Carvykti
    5. Cetrelimab
    6. Daratumumab
    7. Erdafitinib
    8. Genmab
    9. Golimumab
   10. Guselkumab
   11. Ibrutinib
   12. Lazertinib
   13. Nipocalimab
   14. Posdinemab
   15. Talquetamab
   16. Teclistamab
   17. Ustekinumab

AbbVie:
-------
    1. Budigalimab
    2. Concept
    3. Elezanumab
    4. Epcoritamab
    5. Genmab
    6. Livmoniplimab
    7. Lutikizumab
    8. Mirvetuximab
    9. Pivekimab
   10. Ravagalimab
   11. Risankizumab
   12. Telisotuzumab
   13. Telisotuzumab Vedotin
   14. Temab
   15. Upadacitinib

Sanofi:
-------
    1. Amlitelimab
    2. Frexalimab
    3. Itepekimab
    4. Name
Amlitelimab
    5. Name
Frexalimab
    6. Name
Itepekimab
    7. Name
Rilzabrutinib
    8. Name
Teplizumab
    9. Name
Tolebrutinib
   10. Rilzabrutinib
   11. Teplizumab
   12. Tolebrutinib

Merck KGaA:
-----------
    1. Bezlotoxumab
    2. Clesrovimab
    3. Ifinatamab Deruxtecan
    4. Nemtabrutinib
    5. Patritumab Deruxtecan
    6. Pembrolizumab
    7. Quavonlimab
    8. Sacituzumab Tirumotecan
    9. Sotatercept
   10. Zilovertamab Vedotin

GlaxoSmithKline (GSK):
----------------------
    1. Belantamab
    2. Belimumab
    3. Cobolimab
    4. Depemokimab
    5. Dostarlimab
    6. Gsk2857914 Belantamab
    7. Gsk3511294 † Depemokimab
    8. Gsk4069889 (Tsr-022) † Cobolimab
    9. Gsk4527223 (Al-001) † Latozinemab
   10. Latozinemab
   11. Mepolizumab
   12. Momelotinib


Summary by Company:
====================
  Merck & Co.: 1 drugs
  Bristol Myers Squibb: 3 drugs
  Roche/Genentech: 2 drugs
  AstraZeneca: 20 drugs
  Pfizer: 1 drugs
  Novartis: 1 drugs
  Gilead Sciences: 1 drugs
  Amgen: 1 drugs
  Regeneron Pharmaceuticals: 13 drugs
  BioNTech: 0 drugs
  BeiGene: 10 drugs
  Seagen: 0 drugs
  Incyte: 1 drugs
  Vertex Pharmaceuticals: 0 drugs
  Moderna: 0 drugs
  Johnson & Johnson: 17 drugs
  AbbVie: 15 drugs
  Eli Lilly: 0 drugs
  Sanofi: 12 drugs
  Bayer: 0 drugs
  Takeda Pharmaceutical: 0 drugs
  Daiichi Sankyo: 0 drugs
  Astellas Pharma: 0 drugs
  Boehringer Ingelheim: 0 drugs
  Alnylam Pharmaceuticals: 0 drugs
  Illumina: 0 drugs
  Merck KGaA: 10 drugs
  GlaxoSmithKline (GSK): 12 drugs
  CSL: 0 drugs
  Biogen: 0 drugs